Journal of Applied Physiology, Vol 65, Issue 1 137-145, Copyright © 1988 by American Physiological Society

ARTICLES

Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity

M. P. Sherman, J. B. D'Ambola, E. E. Aeberhard and C. T. Barrett
Department of Pediatrics, University of California, Los Angeles 90024.

Because in vitro studies indicate that pulmonary alveolar macrophages (PAM's) filled with phospholipid vesicles have depressed microbicidal capacity, we tested the intrapulmonary bactericidal activity of newborn PAM's after surfactant treatment. Term newborn rabbits received intratracheally either homologous surfactant or one of two artificial phospholipid vesicle preparations followed by pulmonary aerosol infection with group B streptococci (GBS). Four hours after lung infection, phagocytic killing of GBS was reduced by 70-90% in animals treated with the homologous and one of the artificial surfactants compared with untreated animals or animals that received intrapulmonary injections of the surfactant vehicle (P less than 0.02). The other artificial phospholipid preparation decreased intrapulmonary inactivation of GBS by 30-40% compared with the controls. The phospholipid vesicles in the three preparations were avidly ingested and processed by newborn PAM's. The diminished in vivo killing of GBS was not attributed to decreased viability or phagocytic behavior of the PAM's toward GBS. The bactericidal defect that was evident in the newborn PAM's appeared related to the uptake of large phospholipid vesicles in the preparations rather than to the phospholipid content of the surfactants themselves. When in vitro conditions that stimulated the alveolar environment were used, the natural surfactant preparation promoted GBS proliferation, whereas the artificial preparations did not. Our findings indicate that surfactant administration reduces the bactericidal activity of neonatal PAM's. We conclude that additional investigations are needed to ascertain the effect of surfactant replacement therapy on lost defenses of the lung.

This article has been cited by other articles:

				J. A. Wofford and J. R. Wright Surfactant protein A regulates IgG-mediated phagocytosis in inflammatory neutrophils Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1437 - L1443. [Abstract] [Full Text] [PDF]

				H. A. Hein and M. A. Lofgren The Changing Pattern of Neonatal Mortality in a Regionalized System of Perinatal Care: A Current Update Pediatrics, November 1, 1999; 104(5): 1064 - 1069. [Abstract] [Full Text]

				E. HERTING, X. GAN, P. RAUPRICH, C. JARSTRAND, and B. ROBERTSON Combined Treatment with Surfactant and Specific Immunoglobulin Reduces Bacterial Proliferation in Experimental Neonatal Group B Streptococcal Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1862 - 1867. [Abstract] [Full Text]

				A. SUWABE, K. OTAKE, N. YAKUWA, H. SUZUKI, M. ITO, H. TOMOIKE, Y. SAITO, and K. TAKAHASHI Artificial Surfactant (Surfactant TA) Modulates Adherence and Superoxide Production of Neutrophils Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1890 - 1899. [Abstract] [Full Text] [PDF]

				E. Herting, B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 3F - 8. [Abstract] [Full Text]